Product Liability Claims: Legal Theories and Claimant Rights

Product liability law governs the legal responsibility of manufacturers, distributors, and sellers when a defective product causes harm to a consumer or bystander. This page covers the three principal legal theories available to claimants, the regulatory bodies that intersect with product safety, procedural considerations, and the factual boundaries that determine whether a claim is viable. Understanding these frameworks matters because product liability sits at the intersection of tort law, federal safety regulation, and state statutory schemes — with outcomes that can vary significantly depending on jurisdiction and theory of recovery.

Definition and Scope

Product liability is a branch of tort law that holds parties in a product's commercial chain accountable for physical injury, property damage, or death caused by a defective product. Unlike ordinary negligence claims, product liability in most U.S. jurisdictions does not require proof that any particular party acted carelessly — strict liability theories allow a claimant to establish liability without demonstrating fault.

The scope of a product liability claim extends to any tangible good placed into the stream of commerce: manufactured goods, component parts, raw materials, prescription drugs, medical devices, and, in some jurisdictions, software embedded in physical systems. Real property and professional services are generally excluded, though courts occasionally apply product liability principles to hybrid goods-and-services transactions.

Potentially liable parties across the supply chain include:

1. Manufacturers of the finished product
2. Component part manufacturers whose defective part contributed to the harm
3. Assemblers or installers who alter the product's condition
4. Wholesalers and distributors in the chain of distribution
5. Retailers who sold the product to the end consumer

Federal regulatory agencies establish baseline safety standards that are relevant — though not determinative — in civil litigation. The Consumer Product Safety Commission (CPSC) administers the Consumer Product Safety Act (15 U.S.C. § 2051 et seq.), which sets mandatory safety standards and recall authority for thousands of consumer products. The Food and Drug Administration (FDA) regulates drugs, biologics, and medical devices under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. § 301 et seq.). Compliance with these federal standards creates a regulatory record that may be introduced as evidence, but compliance alone does not bar a product liability claim under most state tort systems.

How It Works

Three distinct legal theories structure the majority of product liability claims. Each requires a different set of proven elements and carries different evidentiary burdens — see Burden of Proof Standards for a comparative breakdown.

Theory 1: Strict Liability
Strict liability, adopted by most U.S. states following the Restatement (Second) of Torts § 402A (American Law Institute, 1965) and refined in the Restatement (Third) of Torts: Products Liability (1998), holds a seller liable if:

• The product was in a defective condition unreasonably dangerous to the user
• The defect existed at the time it left the seller's control
• The defect caused the plaintiff's injury
• The plaintiff used the product in a reasonably foreseeable manner

No proof of negligence is required. The plaintiff must show the product was defective — not that anyone was careless in creating that defect.

Theory 2: Negligence
Under a negligence theory, the claimant must prove the defendant owed a duty of reasonable care, breached that duty in the design, manufacture, or marketing of the product, and that the breach proximately caused harm. The elements of negligence apply fully: duty, breach, causation, and damages. Expert testimony is often required to establish what a reasonably prudent manufacturer would have done differently.

Theory 3: Breach of Warranty
Warranty-based claims arise under Article 2 of the Uniform Commercial Code (UCC), which governs sales of goods in all 50 states. Two warranty types are actionable:

• Express warranty: A written or oral representation about the product's characteristics or performance
• Implied warranty of merchantability: An automatic guarantee that a product is fit for its ordinary purpose

Warranty claims may carry shorter notice requirements and privity limitations that differ from tort-based theories.

Defect Classifications
Regardless of the theory pursued, plaintiffs must identify the type of defect alleged:

• Manufacturing defect: The specific unit deviated from the intended design (e.g., a cracked weld in an otherwise sound design)
• Design defect: The entire product line is unreasonably dangerous as designed, evaluated under either the consumer expectations test or the risk-utility balancing test
• Warning defect (failure to warn): The product lacked adequate instructions or warnings about known, non-obvious risks

Common Scenarios

Product liability claims arise across a broad range of product categories. The following scenarios represent recurring fact patterns recognized in U.S. courts:

• Pharmaceutical drugs: A drug manufacturer fails to adequately disclose a known adverse interaction discovered post-approval. FDA adverse event reporting obligations under 21 C.F.R. Part 314 create a regulatory record that claimants use to establish the manufacturer's knowledge timeline.
• Medical devices: A hip implant fails prematurely due to a design defect in metal-on-metal contact surfaces. Both premarket approval (PMA) and 510(k)-cleared devices have generated mass tort claims organized through multidistrict litigation in federal courts.
• Consumer electronics: A lithium-ion battery pack ignites due to a manufacturing defect. The CPSC may issue a recall, which creates public documentation of the defect without itself resolving civil liability.
• Children's products: A toy's small detachable component poses a choking hazard inconsistent with CPSC age-grading regulations under 16 C.F.R. Part 1501.
• Automotive components: An airbag inflator deploys with excessive force, causing secondary injury. National Highway Traffic Safety Administration (NHTSA) recall investigations under 49 U.S.C. § 30118 produce technical reports relevant to the defect determination.
• Food products: A contaminated food product causes illness. The FDA Food Safety Modernization Act (FSMA), signed into law in 2011, expanded preventive control requirements that inform the standard of care in negligence-based food liability claims.

When the same defective product harms a geographically dispersed claimant population, individual suits are frequently consolidated. See Multidistrict Litigation Explained for how federal courts manage these aggregated proceedings.

Decision Boundaries

Not every injury involving a product gives rise to a viable product liability claim. Factual and legal boundaries govern which claims proceed and which do not.

Statute of Limitations
States impose filing deadlines that range from 2 to 6 years depending on the jurisdiction and the theory asserted. Statutes of repose — distinct from statutes of limitation — extinguish claims entirely after a fixed period from the product's manufacture or sale, regardless of when injury occurs. Detailed deadline information by claim type appears at Legal Claim Filing Deadlines Reference.

Preemption
Federal preemption is a critical threshold question. When Congress expressly preempts state tort law — as with certain medical device claims following Riegel v. Medtronic, Inc., 552 U.S. 312 (2008) — PMA-approved devices receive immunity from state design defect and warning claims that impose requirements different from federal standards. Pharmaceutical labeling preemption, by contrast, is narrower following Wyeth v. Levine, 555 U.S. 555 (2009), which held that FDA approval does not automatically bar state failure-to-warn claims.

Comparative Fault
Most states apply comparative fault principles that reduce or bar recovery based on the claimant's own conduct. Pure comparative fault states (including California and New York) reduce damages proportionally. Modified comparative fault states bar recovery if the plaintiff's share of fault exceeds 50% or 51%, depending on the jurisdiction. See Comparative Fault in U.S. Claims for state-by-state structure.

Causation Requirements
Product liability claimants must establish both factual causation ("but for" the defect, the injury would not have occurred) and proximate causation (the injury was a foreseeable result of the defect). In pharmaceutical and toxic-tort cases, courts impose heightened causation standards requiring general causation (the substance can cause this type of injury) and specific causation (it caused this plaintiff's injury), typically through qualified expert testimony under Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993).

Damages Available
Recoverable damages in product liability cases include compensatory damages (medical expenses, lost wages, pain and suffering) and, where the defendant's conduct meets the applicable threshold of egregious misconduct, punitive damages. The availability and cap on punitive damages varies by state statute. The damages types overview covers the classification framework across U.S. civil claims.

References

• Consumer Product Safety Commission (CPSC) — administers the Consumer Product Safety Act, 15 U.S.C. § 2051 et seq.
• U.S. Food and Drug Administration (FDA) — regulates drugs and medical devices under the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 301 et seq.; adverse event reporting at 21 C.F.R. Part 314
• National Highway Traffic Safety Administration (NHTSA) — recall authority under 49 U.S.C. § 30118
• [American Law Institute — Restatement (Third) of Torts: Products Liability (1998)](https://www.ali.org/publications/